Clinical Trials in Salt Lake City

Showing 10581-10600 of 16,694 trials

Discovering the Gene(s) Causing Developmental Dysplasia of the Hip (DDH)

NCT01193673

The primary objective of the study is to find the gene(s) responsible for causing DDH. The secondary objective of the study is to determine the mode of genetic transmission of DDH.

Hip Dysplasia

University of Utah160 participantsStarted Jan 2010

Salt Lake City, Utah, United States

COMPLETEDPhase 2< 1 mile

Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)

NCT01672853

The purpose of this study is to evaluate whether simtuzumab (GS-6624) is effective at preventing the progression of liver fibrosis in adults with primary sclerosing cholangitis (PSC).

Primary Sclerosing Cholangitis (PSC)

Gilead Sciences235 participantsStarted Mar 2013

Phoenix, Arizona, United States • Tucson, Arizona, United States • Chula Vista, California, United States +72 more locations

Discovering the Gene(s) Causing Developmental Dysplasia of the Hip (DDH)

Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)

Find Trials by Condition in Salt Lake City

Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea

PECARN Emergency Care Registry

Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes

Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer

A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)

Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.

MIRODERM H2H DFU Study

Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor

A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

OrthoPulse 2.0 and 2.1 Feasibility Evaluation

A Phase 2 Multi-Center Study of Entinostat (SNDX-275) in Patient With Relapsed or Refractory Hodgkin's Lymphoma

A Study of GDC-0919 and Atezolizumab Combination Treatment in Participants With Locally Advanced or Metastatic Solid Tumors

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris

Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma

A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study)

Dose-ranging Study of Nemolizumab in Atopic Dermatitis

Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure